Results of a xenograft animal study indicated that treatment of SB431542, an inhibitor of the TGFβ/Smad pathway, reduced the tumor growth of human bladder carcinoma cells in vivo [29]. This evidence concerns the gene TGFB1 and urinary bladder carcinoma.